Davriellelouna@lemmy.world to News@lemmy.world · 1 day ago‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comexternal-linkmessage-square66linkfedilinkarrow-up1530arrow-down13cross-posted to: [email protected][email protected][email protected]
arrow-up1527arrow-down1external-link‘HIV-ending’ drug could be made for just $25 per patient a year, say researcherswww.theguardian.comDavriellelouna@lemmy.world to News@lemmy.world · 1 day agomessage-square66linkfedilinkcross-posted to: [email protected][email protected][email protected]
minus-squarenull_dot@lemmy.dbzer0.comlinkfedilinkEnglisharrow-up1·6 hours agoI don’t really know bit my supposition would be that eradication isn’t really on the table presently. This is only a prophylactic. There are people right now with HIV who (excluding a “cure” emerging) will be potentially infectious in 40 or 50 years. In the short to medium term making this accessible to populations in areas with a high prevalence could avoid millions of infections.
I don’t really know bit my supposition would be that eradication isn’t really on the table presently.
This is only a prophylactic. There are people right now with HIV who (excluding a “cure” emerging) will be potentially infectious in 40 or 50 years.
In the short to medium term making this accessible to populations in areas with a high prevalence could avoid millions of infections.